SANTA CLARA, Calif.–(Company WIRE)–Omnicell, Inc. (Nasdaq:OMCL), a top supplier of medication administration solutions and adherence tools for healthcare programs and pharmacies, announced that they will current at the 41st Annual J.P. Morgan Healthcare Meeting on Wednesday, January 11, 2023 at 8:15 a.m. Pacific Time.
Dwell and archived webcasts of the presentation will be readily available via the Omnicell web-site at: https://ir.omnicell.com/functions-and-shows/
Considering the fact that 1992, Omnicell has been dedicated to reworking the pharmacy care supply product to dramatically increase results and decreased charges. By the eyesight of the autonomous pharmacy, a blend of automation, intelligence, and know-how-enabled providers, powered by a cloud information system, Omnicell supports a lot more productive methods to manage medications throughout all care settings. Healthcare amenities worldwide use Omnicell automation and analytics solutions to enable boost operational effectiveness, decrease medicine faults, provide actionable intelligence, and enhance individual security. Institutional and retail pharmacies throughout North The usa and the United Kingdom leverage Omnicell’s revolutionary treatment adherence and population health methods to improve individual engagement and adherence to prescriptions, assisting to lower highly-priced hospital readmissions. To learn extra, stop by www.omnicell.com.
OMNICELL and the Omnicell emblem are registered logos and Omnicell A single is a trademark of Omnicell, Inc. or one particular of its subsidiaries.
To the extent any statements contained in this press launch deal with details that is not historical, these statements are “forward-seeking statements” in the which means of the Personal Securities Litigation Reform Act of 1995. Without having limiting the foregoing, statements like the text “expect,” “intend,” “may,” “will,” “should,” “would,” “could,” “plan,” “potential,” “anticipate,” “believe,” “forecast,” “guidance,” “outlook,” “goals,” “target,” “estimate,” “seek,” “predict,” “project,” and identical expressions are meant to discover ahead-on the lookout statements. Forward-searching statements are subject matter to the event of several events exterior Omnicell’s control. These kinds of statements include, but are not restricted to planned new solutions and expert services and the connected predicted gains (and any implied monetary affect), and statements about Omnicell’s tactic, designs, aims, plans, and vision. Real effects and other functions could differ noticeably from people contemplated by forward-seeking statements due to numerous elements that involve substantial acknowledged and not known pitfalls and uncertainties. These pitfalls and uncertainties consist of, amongst other points, (i) dangers relevant to the ongoing COVID-19 pandemic (which includes new variants of the virus), (ii) Omnicell’s potential to consider edge of expansion possibilities and acquire and commercialize new solutions and boost present options, (iii) ongoing and greater levels of competition from present and long run competitors in the medicine administration automation answers current market and the treatment adherence methods sector, (iv) unfavorable basic economic and current market situations or reduction in demand for our answers, (v) dangers related to Omnicell’s investments in new organization tactics or initiatives, such as its changeover to marketing extra items and expert services on a subscription basis, (vi) any disruption in Omnicell’s facts technologies units and breaches of information stability or cyber-assaults on its units or remedies, (vii) Omnicell’s means to secure its mental assets, (viii) Omnicell’s ability to fulfill the calls for of, or sustain relationships with, its institutional, retail, and specialty pharmacy shoppers, (ix) hazards relevant to the availability and resources of uncooked resources and factors or value fluctuations, shortages, or interruptions of supply, (x) Omnicell’s dependence on a minimal number of suppliers for sure parts, tools, and uncooked materials, as very well as systems presented by third-get together distributors, and (xi) other risks and uncertainties additional described in the “Risk Factors” area of Omnicell’s most recent Annual Report on Kind 10-K and subsequent quarterly experiences on Form 10-Q, as perfectly as in Omnicell’s other studies submitted with or furnished to the United States Securities and Exchange Commission (“SEC”), offered at www.sec.gov. Forward-searching statements need to be considered in light-weight of these dangers and uncertainties. Traders and others are cautioned not to put undue reliance on ahead-searching statements. All ahead-searching statements contained in this push launch speak only as of the date of this push release. Omnicell assumes no obligation to update any these statements publicly, or to update the causes genuine success could vary materially from those expressed or implied in any ahead-looking statements, irrespective of whether as a result of modified circumstances, new details, foreseeable future events, or normally, other than as needed by legislation.